Acute Kidney Injury (AKI) can occur during common hospital procedures including open heart surgery, minimally invasive heart cath procedures, and with ICU patients.
RenalGuard is the only system offering a complete solution to patients at risk of AKI.
The device is CE-marked for sale in Europe and a variety of countries throughout the world, and is under investigation in the U.S.Click here to watch video.
RenalGuard is CE-marked for the intended use of temporary (up to 14 days) replacement of urine output by infusion of a matched volume of sterile replacement solution to maintain a patient’s intravascular fluid volume. The RenalGuard System is not intended for infusion of blood, blood components, medications, or nutritional fluids. All treatments administered via The RenalGuard System must be prescribed by a physician. RenalGuard Solutions, Inc. reserves the right to modify the specifications and features described herein, or discontinue manufacture of the product described at any time without prior notice or obligation.
Caution - Investigational Device, Limited By United States Law to Investigational Use.
This site contains medical information that is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns.